Novel Applications of Toll-Like Receptor Ligands in Non-Pharmaceutical Industries

Publication ID: 24-11857577_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Novel Applications of Toll-Like Receptor Ligands in Non-Pharmaceutical Industries,” Published Technical Disclosure No. 24-11857577_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857577_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,577.

Summary of the Inventive Concept

This inventive concept leverages the core technology of toll-like receptor ligands from Gram-positive bacteria to create novel solutions for agricultural crop enhancement, oil recovery, wastewater treatment, environmental monitoring, and bioremediation, opening up new markets and industries beyond pharmaceutical applications.

Background and Problem Solved

The original patent focused on the therapeutic treatment of hepatic diseases and disorders. However, the limitations of the original patent lie in its narrow scope, failing to explore the vast potential of toll-like receptor ligands in other industries. This inventive concept addresses this limitation by applying the core technology to entirely new fields, providing innovative solutions to pressing problems.

Detailed Description of the Inventive Concept

The newly generated claims describe a system for improving agricultural crop yields by applying toll-like receptor ligand-containing compositions to the soil or plants, enhancing oil recovery from oil wells by injecting toll-like receptor ligand-containing formulations, treating wastewater by breaking down organic matter with toll-like receptor ligand-containing compositions, monitoring environmental pollutants using toll-like receptor ligand-detecting sensors, and improving bioremediation of contaminated soil by stimulating microbial growth with toll-like receptor ligand-containing compositions. These innovative applications capitalize on the immunomodulatory effects of toll-like receptor ligands to drive positive outcomes in diverse industries.

Novelty and Inventive Step

The novelty of this inventive concept lies in its application of toll-like receptor ligands to non-pharmaceutical industries, providing a previously unexplored avenue for innovation. The inventive step is the recognition of the potential for toll-like receptor ligands to have a significant impact beyond pharmaceutical applications, coupled with the development of novel compositions, systems, and methods tailored to these new industries.

Alternative Embodiments and Variations

Alternative embodiments may include using different types of bacteria or ligands, varying the composition and formulation of the toll-like receptor ligand-containing solutions, or integrating these solutions with existing technologies in each industry. Variations may also involve adapting the technology for use in other industries, such as cosmetics, food processing, or biotechnology.

Potential Commercial Applications and Market

The potential commercial applications of this inventive concept are vast, with potential markets including agriculture, oil and gas, wastewater treatment, environmental monitoring, and bioremediation. The technology has the potential to improve crop yields, increase oil recovery, reduce wastewater contaminants, monitor environmental pollutants, and enhance bioremediation, offering significant economic and environmental benefits.

Field of Art

Biotechnology and microbial composition applications, with expertise in toll-like receptor ligand technologies, bacterial lysates, and cross-industry biological system modifications

Person of Ordinary Skill (PHOSITA) Profile

A skilled practitioner with advanced degrees in microbiology, biotechnology, or chemical engineering, possessing knowledge of bacterial interactions, receptor signaling, and interdisciplinary applications of microbial compounds

Obviousness Rationale

The PTD represents a straightforward extension of the source patent's core technology by applying toll-like receptor ligand compositions to alternative industrial contexts. A PHOSITA would recognize the fundamental immunomodulatory properties of bacterial lysates as transferable across different technological domains. The compositional similarities and known biological mechanisms make these variations predictable and obvious adaptations of the original pharmaceutical-focused invention.

Obvious Combinations & Variations

Source Patent Element
Liquid formulation containing lysate and/or cell wall extract from Gram-positive bacteria with TLR ligands
PTD Variation
Agricultural crop enhancement through soil and plant application of bacterial lysates
Obviousness Reasoning
Known biological stimulation mechanisms make bacterial lysate interactions with plant systems a predictable and obvious technological extension
Source Patent Element
Pharmaceutical composition activating toll-like and Nod-like receptors
PTD Variation
Environmental monitoring systems using ligand-detecting sensors
Obviousness Reasoning
Sensor technologies for detecting receptor interactions are well-established, representing a routine application of known detection principles
Source Patent Element
Immunomodulatory compositions targeting cellular receptor interactions
PTD Variation
Bioremediation methods stimulating microbial growth through bacterial lysate compositions
Obviousness Reasoning
Microbial growth stimulation through receptor activation is a predictable outcome using known biological interaction principles
Source Patent Element
Liquid formulation with buffer and bacterial cell wall extracts
PTD Variation
Wastewater treatment compositions using bacterial lysate organic matter breakdown
Obviousness Reasoning
Enzymatic and biological breakdown mechanisms are well-understood, making this application an obvious technological adaptation
Source Patent Element
Pharmaceutical compositions targeting cellular receptor interactions
PTD Variation
Oil recovery enhancement through ligand-containing injection formulations
Obviousness Reasoning
Applying known biological interaction principles to industrial processes represents a standard engineering approach to technology transfer
35 U.S.C. § 103 Summary: Under 35 U.S.C. ยง 103, the variations disclosed in this publication would be considered obvious extensions of US Patent 11857577, as a Person Having Ordinary Skill In The Art would recognize the straightforward applicability of toll-like receptor ligand compositions across multiple technological domains, with predictable results achieved through routine engineering adaptations.

Original Patent Information

Patent NumberUS 11,857,577
TitleCompositions and methods for the treatment of hepatic diseases and disorders
Assignee(s)Labyrinth Holdings, LLC